251 related articles for article (PubMed ID: 14278178)
1. THE RENAL EXCRETION OF OXYPURINES.
GOLDFINGER S; KLINENBERG JR; SEEGMILLER JE
J Clin Invest; 1965 Apr; 44(4):623-8. PubMed ID: 14278178
[No Abstract] [Full Text] [Related]
2. [TREATMENT OF GOUTY DYSPURINIA BY PARAMETABOLITES AND, ESPECIALLY, BY A XANTHINE OXIDASE INHIBITOR].
DELBARRE F; AUSCHER C; LABROUSSE C; GERYA DE
Presse Med (1893); 1965 May; 73():1275-9. PubMed ID: 14273211
[No Abstract] [Full Text] [Related]
3. 4-HYDROXYPYRAZOLO (3,4-D) PYRIMIDINE (HPP) IN THE TREATMENT OF GOUT: PRELIMINARY OBSERVATIONS.
HALL AP; HOLLOWAY VP; SCOTT JT
Ann Rheum Dis; 1964 Nov; 23(6):439-46. PubMed ID: 14229577
[No Abstract] [Full Text] [Related]
4. EFFECT OF ALLOPURINOL (4-HYDROXYPYRAZOLO-(3,4-D)PYRIMIDINE) ON SERUM AND URINARY URIC ACID IN PRIMARY AND SECONDARY GOUT.
YUE TF; GUTMAN AB
Am J Med; 1964 Dec; 37():885-98. PubMed ID: 14246090
[No Abstract] [Full Text] [Related]
5. THE MODERN MANAGEMENT OF GOUT.
MARSON FG
Appl Ther; 1964 Apr; 6():326-9 CONTD. PubMed ID: 14152075
[No Abstract] [Full Text] [Related]
6. THE EFFECTIVENESS OF THE XANTHINE OXIDASE INHIBITOR ALLOPURINOL IN THE TREATMENT OF GOUT.
KLINENBERG JR; GOLDFINGER SE; SEEGMILLER JE
Ann Intern Med; 1965 Apr; 62():639-47. PubMed ID: 14274828
[No Abstract] [Full Text] [Related]
7. FACTORS INFLUENCING RENAL EXCRETION OF FOREIGN ORGANIC ACIDS.
WEINER IM; BLANCHARD KC; MUDGE GH
Am J Physiol; 1964 Nov; 207():953-63. PubMed ID: 14237469
[No Abstract] [Full Text] [Related]
8. TREATMENT OF THE PATIENT WITH GOUT.
DENKO CW
Ohio State Med J; 1963 Nov; 59():1098-101. PubMed ID: 14083462
[No Abstract] [Full Text] [Related]
9. EXHIBIT ON GOUT.
RIVERA JV
Bol Asoc Med P R; 1964 May; 56():158-60. PubMed ID: 14169926
[No Abstract] [Full Text] [Related]
10. THE TREATMENT OF GOUT.
TREADWELL B
N Z Med J; 1964 Sep; 63():567-74. PubMed ID: 14210072
[No Abstract] [Full Text] [Related]
11. XANTHINE AS A PRECURSOR OF NUCLEIC ACID PURINES IN THE MOUSE.
POMALES R; ELION GB; HITCHINGS GH
Biochim Biophys Acta; 1965 Mar; 95():505-6. PubMed ID: 14342542
[No Abstract] [Full Text] [Related]
12. THE STUDY OF PURINE UTILIZATION AND EXCRETION IN A XANTHINURIC MAN.
AYVAZIAN JH; SKUPP S
J Clin Invest; 1965 Jul; 44(7):1248-60. PubMed ID: 14328401
[No Abstract] [Full Text] [Related]
13. Effect of probenecid on oxypurines in plasma.
Yamamoto T; Takahashi S; Suda M; Hada T; Higashino K
Int J Clin Pharmacol Ther Toxicol; 1989 Oct; 27(10):510-4. PubMed ID: 2511159
[TBL] [Abstract][Full Text] [Related]
14. Treatment of gout.
Goldfinger SE
N Engl J Med; 1971 Dec; 285(23):1303-6. PubMed ID: 4941493
[No Abstract] [Full Text] [Related]
15. REGULATION OF XANTHINE DEHYDROGENASE IN CHICK LIVER. EFFECT OF STARVATION AND OF ADMINISTRATION OF PURINES AND PURINE NUCLEOSIDES.
STIRPE F; DELLACORTE E
Biochem J; 1965 Feb; 94(2):309-13. PubMed ID: 14348191
[TBL] [Abstract][Full Text] [Related]
16. Renal excretion of purine bases. Effects of probenecid, benzbromarone and pyrazinamide.
Yamamoto T; Moriwaki Y; Takahashi S; Hada T; Higashino K
Nephron; 1988; 48(2):116-20. PubMed ID: 3344050
[TBL] [Abstract][Full Text] [Related]
17. GOUT.
REAH TG
Practitioner; 1964 Sep; 193():306-14. PubMed ID: 14213731
[No Abstract] [Full Text] [Related]
18. Pharmacologic evaluation of the renal handling of uric acid and oxypurines.
Hiroshige K; Takasugi M; Yuu K; Kuroiwa A
Nihon Jinzo Gakkai Shi; 1994 Nov; 36(11):1268-75. PubMed ID: 7853759
[TBL] [Abstract][Full Text] [Related]
19. A quantitative study of skeletal-muscle purines and pyrazolo(3,4-d)pyrimidines in gout patients treated with allopurinol.
Watts RW; Snedden W; Parker RA
Clin Sci; 1971 Aug; 41(2):153-8. PubMed ID: 5564305
[No Abstract] [Full Text] [Related]
20. A comparative study of the xanthine oxidase inhibitors allopurinol and oxipurinol in man.
Chalmers RA; Krömer H; Scott JT; Watts RW
Clin Sci; 1968 Oct; 35(2):353-62. PubMed ID: 5721238
[No Abstract] [Full Text] [Related]
[Next] [New Search]
